Abbvie lowers annual profit forecast due to $2.7 billion in R&D spending

智通財經
2025.10.04 02:33
當地時間 10 月 3 日，艾伯維在一份監管文件中表示，預計其第三季度業績將計入 27 億美元在研項目支出的相關費用。艾伯維表示，受第三季度該筆支出影響，公司第三季度調整後每股攤薄收益將在 1.74 至 1.78 美元之間。同時，艾伯維將全年調整後每股攤薄收益預期從先前預測的 11.88-12.08 美元下調至 10.38-10.58 美元。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.